UK Life Sciences Company Directory

Targeted nanoparticles for in vivo CAR-T and gene delivery

Deliver Biosciences is a biotechnology company developing targeted nanoparticle vectors for in vivo cell and gene therapies. Its delivery platform transports genetic payloads, including DNA and mRNA, into selected cell types using programmable targeting components. Its lead programme aims to engineer T cells inside…

Cheminformatics workflow and scientific data management software

Informatics Matters is a scientific software company developing cheminformatics platforms and computational workflows for pharmaceutical and biotechnology research. Its Squonk platform enables reproducible computational chemistry workflows, including compound screening and data processing, while Fragnet Search…

Nanotechnology-based point-of-care cardiovascular diagnostics for decentralised healthcare

The NanoBioTechnology Hub is a Manchester-based developer of miniaturised point-of-care diagnostic devices using nanotechnology and biotechnology. The company is developing an ultra-sensitive handheld device for pre-hospital cardiovascular biomarker analysis, using lateral flow technology and biointerfaced…

Macrophage-targeted therapeutics for oncology, neurological and fibrotic diseases

Macomics is a University of Edinburgh spin-out developing macrophage-targeted medicines across oncology, neurodegenerative, inflammatory and fibrotic diseases. Its ENIGMAC drug discovery platform combines human macrophage and microglia models derived from induced pluripotent stem cells, gene editing and…

Algal biotechnology company developing Chlorella-based food ingredients

Algenuity Limited is an algal biotechnology company that develops and supplies Chlorella-based ingredients for food and beverage manufacturers. Using proprietary strain engineering and heterotrophic fermentation, the company produces white Chlorella, a neutral-coloured, allergen-free, protein-rich ingredient suitable…

ADC oncology company developing novel spliceosome-modulating payloads

Akari Therapeutics is a clinical-stage biopharma company developing next-generation bi-functional antibody-drug conjugates for cancer treatment. Its proprietary ADC platform centres on PH1, a novel spliceosome-modulating small molecule payload designed to disrupt RNA splicing in tumour cells and activate anti-tumour…

Long-acting eye-drop matrix technology for chronic ocular surface disease

Healome Therapeutics is a University of Birmingham spin-out developing a proprietary eye-drop matrix technology that improves drug retention, lubrication and healing on the eye surface. Unlike conventional eye drops, which clear within minutes and often require dosing many times a day, Healome's platform behaves like…

Ultra-sensitive DNA detection platform

InvenireX is developing a nucleic acid detection platform that uses programmable DNA nanostructures captured within microfluidic chips, read by a proprietary AI-powered imaging system. The technology detects genetic markers at concentrations below the threshold of conventional methods such as PCR, with potential to…

Targeted transcriptomic sequencing services for diagnostics and drug discovery

BioClavis is a genomics R&D and services laboratory leveraging their targeted RNA sequencing platform for high-throughput transcriptomic and biomarker analysis. The platform enables customisable gene expression profiling from crude cell lysates and archival FFPE tissue without nucleic acid purification, making it…

Baculovirus expression systems, research reagents and contract protein production

Oxford Expression Technologies is an Oxford Brookes University and NERC spin-out specialising in recombinant protein expression. Its flashBAC baculovirus expression systems, transfer vectors and engineered insect cell lines support protein production for pharmaceutical, vaccine and diagnostic research. The company…

Specialist oncology CRO for early and late phase clinical trials

Theradex (Europe) Limited is the European arm of Theradex Oncology, a US-founded CRO with over 40 years specialising in oncology clinical development. The company provides full-service clinical trial management for pharma and biotech sponsors across early and late phase studies, with expertise in oncology,…

Human ovarian cell models and multi-omics drug discovery

OvartiX is a Cambridge biotechnology company developing drug-discovery tools and therapeutic programmes for ovarian and reproductive health. Its platform combines human multi-omics datasets, machine learning and engineered two- and three-dimensional ovarian cell models to identify and validate disease targets. Founded…

Microbiome emulation platform for drug development de-risking

BioCorteX is a biotech company that applies computational emulation to model interactions between drugs, the human microbiome, and the immune system. Its platform uses physics- and chemistry-based simulation to generate in-silico predictions of drug-bacteria interactions across diverse patient populations. The…

AI-powered immune profiling platform for precision medicine

IMU Biosciences is a biotechnology company coupling high-resolution, systems-level immune profiling with proprietary AI analytics to build a detailed atlas of the human immune system across health and disease. Its platform can identify and analyse over 2,000 immune cell subsets from blood samples, generating…

Glycan analysis products and services for biopharmaceutical QC

Ludger is a glycobiology company specialising in the measurement and characterisation of protein glycosylation for biopharmaceutical development and quality control. The company manufactures glycan analysis kits, reagents, and reference standards for use in LC, MS, and CE workflows, and provides contract analytical…

Veterinary vaccine CDMO and aquaculture diagnostics for animal health

Marinnovac UK is a contract research and manufacturing organisation specialising in veterinary vaccine development and viral antigen production for animal and aquaculture health applications. The company holds the only VMD-approved viral autogenous vaccine manufacturing licence in the UK, offering services spanning…

Fluorescent nanoparticle probes and antibody conjugation reagents

Stream Bio is a developer and manufacturer of fluorescent conjugated polymer nanoparticles for biological imaging and diagnostic research. Its visible and near-infrared probes support microscopy, flow cytometry, immunoassays and lateral-flow test development. The company supplies streptavidin-linked reagents and…

Next-generation viral vectors engineered for safer gene therapy delivery

Sandbox Bioscience is a biotechnology company developing next-generation viral delivery vectors for gene therapy. Founded by a team of virologists with extensive experience in gene therapy delivery systems and platform development, the company is engineering vectors designed to improve on existing market solutions…

Cyclic peptide screening platform for first-in-class cancer drugs

Curve Therapeutics is a drug discovery company using its proprietary platform to identify first-in-class small molecule therapeutics against targets that have been difficult to address using conventional methods. The platform screens gene-encoded cyclic peptide libraries inside mammalian cells to identify functionally…

UK distributor of analytical instruments for life science laboratories

Verulam Scientific is a specialist distributor of analytical instruments and laboratory systems serving the UK pharmaceutical, clinical, life science, environmental, and biotechnology markets. The company represents a portfolio of European and US manufacturers, supplying and supporting systems in HPLC electrochemical…